Colorectal cancer is the third leading cause of cancer-related mortality in the world; the main cause of death of colorectal cancer is hepatic metastases, which can be treated with hyperthermia using isolated hepatic perfusion (IHP). In this study, we report that mild hyperthermia potently reduced cellular FLIP(long), (c-FLIP L ), a major regulator of the death receptor (DR) pathway of apoptosis, thereby enhancing humanized anti-DR4 antibody mapatumumab (Mapa)-mediated mitochondria-independent apoptosis. We observed that overexpression of c-FLIP L in CX-1 cells abrogated the synergistic effect of Mapa and hyperthermia, whereas silencing of c-FLIP in CX-1 cells enhanced Mapa-induced apoptosis. Hyperthermia altered c-FLIP L protein stability without concomitant reductions in FLIP mRNA. Ubiquitination of c-FLIP L was increased by hyperthermia, and proteasome inhibitor MG132 prevented heat-induced downregulation of c-FLIP L . These results suggest the involvement of the ubiquitinproteasome system in this process. We also found lysine residue 195 (K195) to be essential for c-FLIP L ubiquitination and proteolysis, as mutant c-FLIP L lysine 195 arginine (arginine replacing lysine) was left virtually un-ubiquitinated and was refractory to hyperthermia-triggered degradation, and thus partially blocked the synergistic effect of Mapa and hyperthermia. Our observations reveal that hyperthermia transiently reduced c-FLIP L by proteolysis linked to K195 ubiquitination, which contributed to the synergistic effect between Mapa and hyperthermia. This study supports the application of hyperthermia combined with other regimens to treat colorectal hepatic metastases. Colorectal cancer is the third leading cause of cancer-related mortality in the world. The main cause of death of patients with colorectal cancer is hepatic metastases. Approximately 25% of patients with colorectal cancer will develop metastatic disease exclusively or largely confined to the liver. Untreated patients with liver metastases share a poor prognosis, with an average survival of 12 months. In contrast, patients whose liver metastatic lesions are surgically treated have an average 5-year survival rate of 40%, but only 10-15% of initial colorectal liver metastases are considered resectable.
The cellular FLICE-inhibitory protein (c-FLIP) is the major inhibitor of the extrinsic apoptotic pathway through inhibition of caspase 8 activation and processing at the death-inducing signaling complex (DISC). 10 Differential splicing gives rise to long form of cellular FLIP (c-FLIP L ) and short (c-FLIP s ) forms of c-FLIP. Both c-FLIP splice variants bind to FADD within the DISC. They compete with caspase 8 for DISC association and can form heteromeric complexes with this caspase of the extrinsic pathway, thereby interfering with its proper activation with the consequence of inhibiting apoptosis. 11, 12 Of note, c-FLIP L , which is the most abundant isoform in many cancer cell lines, is a key regulator of colorectal cancer cell death and associated with a poor prognosis in colorectal cancer patients. [13] [14] [15] Hyperthermia has been explored as an anticancer agent for many decades and is often used with IHP. Our laboratory has focused on identifying strategies and mechanisms for thermal sensitization in an attempt to improve the clinical efficacy of IHP. We previously reported that hyperthermia has a synergistic effect with Mapa or TRAIL in causing cytotoxicity through the mitochondria-dependent pathway. [16] [17] [18] We report here that hyperthermia triggered downregulation of c-FLIP L in all tested cells, albeit at cell-specific levels. The c-FLIP L downregulation subsequently sensitized to apoptosis mediated by Mapa in human colon cancer cells. Additionally, we show that the hyperthermia-induced downregulation of c-FLIP L was due to increased ubiquitination and proteasomal degradation of c-FLIP L . Furthermore, for the first time, lysine residue 195 (K195) was found essential for c-FLIP L ubiquitination and proteolysis, and contributed to the synergistic effect of Mapa and hyperthermia. Our findings indicate that hyperthermia augmented Mapa-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP L in human colon cancer cells.
Results
Hyperthermia enhanced Mapa-induced apoptosis in human colorectal cancer CX-1 cells. To investigate the effect of hyperthermia on Mapa-induced cytotoxicity, the cell viability was determined by MTS assay. CX-1 cells were heated (42 1C for 1 h) in the absence or presence of various concentrations of Mapa (10-1000 ng/ml) and incubated at 37 1C for 72 h, as shown in Figure 1a . Synergistic effect was observed in hyperthermia combined with Mapa in a dosedependent manner. To clarify whether the effect of hyperthermia on Mapa-induced cytotoxicity is associated with apoptosis, CX-1 cells were heated (42 1C for 1 h) in the absence or presence of 100 ng/ml Mapa and incubated at 37 1C for 3 h, and flow cytometric assays were performed. Figure 1b clearly shows that hyperthermia enhanced Mapainduced apoptotic death. Enhancement of apoptosis was also detected by cell cycle studies. The analysis of cell cycle distribution revealed that Mapa treatment alone resulted in an S-phase arrest and sub-G1 (apoptosis) phase accumulation, whereas hyperthermia in combination with Mapa significantly increased sub-G1 phase ( Figure 1c ). We then examined the effect of different temperatures of hyperthermia on Mapa-induced apoptosis. Figure 1d indicates that treatment of cells with Mapa resulted in caspase 8 and 3 activation (cleavage), and thus poly (ADP-ribose) polymerase (PARP) cleavage (the hallmark feature of apoptosis). Interestingly, hyperthermia promoted the activation of caspase 8 (mitochondria-independent pathway), caspase 9 (mitochondria-dependent pathway) and caspase 3 as well as PARP cleavage during treatment with Mapa. Similar results were obtained in human colon cancer stem cells Tu-12, Tu-21 and Tu-22 ( Figure 1e ). As we have previously shown how hyperthermia enhanced Mapa-induced apoptosis through the mitochondria-dependent pathway, 18 in this study we focused on how hyperthermia enhanced Mapainduced apoptosis through the mitochondria-independent pathway. c-FLIP L level was dramatically reduced following hyperthermia on human colorectal cancer cells as well as colon cancer stem cells. c-FLIP is the major inhibitor of the extrinsic apoptotic pathway through inhibition of caspase 8 activation, and we observed that the level of c-FLIP L was reduced after hyperthermia at 41-43 1C for 1 h (Figure 2a ) and as long as 1-4 h (Figure 2b ) in human colon carcinoma CX-1 cells. We also investigated whether this paradigm could be applicable for colon cancer stem cells (Tu-12, Tu-21 and Tu-22); Figure 2c reveals a similar reduction of the level of c-FLIP L in response to temperature-dependent hyperthermia in human colon cancer stem cells. We also observed this phenomenon in mouse embryonic fibroblast (MEF) cells (Figure 6c ), breast cancer cells (Figure 6d ) and head and neck cancer cells (data not shown), which indicated that hyperthermia markedly reduced c-FLIP L in all tested cells, albeit at cell-specific levels.
The synergistic effect of hyperthermia on Mapa-induced apoptosis is correlated with the intracellular level of c-FLIP L in various colon cancer cell lines. Western blot showed that the hyperthermia-induced decrease in the c-FLIP L levels was restored within 3 h during recovery at 37 1C (Figure 3a) . Therefore, we investigated whether the intracellular levels of c-FLIP L correlated with the hyperthermia-induced sensitization to Mapa-mediated apoptosis. Mapa was either treated with hyperthermia simultaneously, or 0-3 h after hyperthermia recovery. The kinetics of c-FLIP reduction and restoration corresponded to the kinetics of hyperthermia-mediated sensitization and desensitization to Mapa-mediated apoptosis (Figure 3b ). To further determine the relationship between the synergistic effect of hyperthermia on Mapa-induced apoptotic death and the expression of c-FLIP L , we examined the correlation between cell death by treatment with Mapa plus hyperthermia and their intracellular levels of c-FLIP L in CX-1, HCT116, Tu-22 and HT29 cells. Cell viability and c-FLIP L levels of these cell lines were detected by MTS assay and immunoblotting assay, respectively ( Figure 3c ). HCT116 had the lowest level of c-FLIP L and showed the highest cell killing by Mapa plus hyperthermia, whereas Tu-22 had the highest c-FLIP L level and exhibited minimal cell death. Cell killing by Mapa plus hyperthermia was plotted as a function of relative level of c-FLIP L (c-FLIP L /actin) (Figure 3d ). The correlation coefficient was calculated to be 0.817 (Po0.05), which indicates a significant negative correlation (Figure 3d ). Collectively, . These results suggest that protein synthesis inhibition is not responsible for downregulation of FLIP L . The other possibility is that c-FLIP L is a thermolabile protein and easily denatured and subsequently degraded during hyperthermia. It is well known that the intracellular degradation of protein occurs in two ways -proteolysis in lysosome and an ubiquitin-dependent process, which targets proteins to proteasome. 19 Indeed, several studies show that c-FLIP L is degraded via the proteasome or lysosome pathway. 20, 21 To verify which pathway was involved in hyperthermiainduced downregulation of c-FLIP L , we used the proteasome inhibitor MG132 and lysosomal proteases inhibitor ammonium chloride (NH 4 Cl). Hyperthermia-induced c-FLIP L degradation is independent of the Itch and UBR1/2 E3 ligases, reactive oxygen species (ROS), JNK and HSP90. Several researchers have reported that c-FLIP expression is regulated by JNKmediated phosphorylation and activation of E3 ubiquitin ligase (Itch). [22] [23] [24] To examine whether Itch has a role in hyperthermia-induced downregulation of c-FLIP L , we generated Itch-knockdown CX-1 cell by infection with lentiviral (Figure 7a ). The online software UbPred (University of California, San Diego, CA, USA), which is a predictor of protein ubiquitination sites, showed that lysine 106 and 195 had the highest score among the 19 lysines in the 1-200-aa region. As lysine is the aa where ubquitination moieties are ligated, we replaced 106 and 195 lysine to arginine and tested the stability of the fulllength c-FLIP L carrying the resulting point mutation. As shown in Figure 7b , in the transfection group, c-FLIP L lysine 106 arginine (K106R) was easily degraded when subjected to hyperthermia, whereas lysine 195 arginine (K195R) was refractory to degradation by hyperthermia. Figure 7c confirmed that c-FLIP L wild type (WT) was efficiently ubiquitinated but not the K195R mutant, which was found virtually without ubiquitination. Finally, we compared the sensitization of hyperthermia with Mapa in the CX-1 c-FLIP L WT and K195R transient transfectants in PARP cleavage (apoptosis) and cell viability. We observed that c-FLIPL K195R-expressing cells were resistant to Mapa in combination hyperthermia-induced apoptotic cell death (Figures 7d  and e) . These results suggest that the transient hyperthermia-mediated degradation of c-FLIP L involved ubiquitination of K195, and K195R mutant conferred resistance against hyperthermia-augmented Mapa-induced apoptotic death.
Discussion
Our laboratory has developed strategies for thermal sensitization in an attempt to improve the clinical efficacy of IHP. We previously reported that hyperthermia has a synergistic effect with Mapa or TRAIL in causing cytotoxicity through the mitochondria-dependent pathway. 28, 29 However, there was a large amount of activated caspase 8 in the combination therapy (Figure 1d ), indicating that the extrinsic apoptotic pathway was also activated by hyperthermia in colon cancer cells. Thus, our interest was to extend our inquiry to solve the molecular mechanisms for the extrinsic pathway in hyperthermia-enhanced apoptotic death. c-FLIP, also known as FLAME-1/I-FLICE/CASPER/CASH/ MRIT/CLARP/Usurpin, is a well-described inhibitor of DRmediated apoptosis. c-FLIP was first described in 1997, and has been shown to be a major inhibitor of procaspase 8 activation at the DISC. The three c-FLIP isoforms comprise: Long (L), Short (S) and Raji (R). All three isoforms possess two DED domains and thereby bind to the DISC. The short FLIP isoforms, c-FLIP S and c-FLIP R , behave as pure inhibitors of procaspase 8 activation. 30 However, the function of c-FLIP L is controversial. It can act as an anti-apoptotic molecule or pro-apoptotic molecule. 31, 32 Whether c-FLIP L accelerates or slows down DR-induced cell death does not only depend on its amount, but also on the cell type and the strength of receptor stimulation. 33 Our experiments with CX-1 cells stably overexpressing c-FLIP L showed that We showed in this study that c-FLIP L level was dramatically reduced, following hyperthermia in human colorectal cancer CX-1 and HCT116 cells, several colon cancer stem cells, breast cancer cells and MEF cells, indicating that hyperthermia reduction of c-FLIP L is a general principle, albeit at cell-specific levels. We observed the sensitizing effect of hyperthermia on Mapa-mediated apoptosis was reduced when the levels of c-FLIP L were restored during recovery from hyperthermia in CX-1 cells. We also observed the negative correlation between the intracellular levels of c-FLIP L and the synergistic effect of hyperthermia on Mapa-induced apoptosis in various colon cancer cells (Figure 3d ). Given the central role of c-FLIP L in extrinsic apoptotic death, we investigated in depth the mechanism of FLIP L downregulation by hyperthermia.
Transcriptionally, c-FLIP expression is known to be regulated by several transcription factors, including NF-kB and p53. 35, 36 In this study, data from qRT-PCR showed that [22] [23] [24] or by the ATM kinase, 26, 27 or ROS. 25 However, other researchers have observed JNK-independent, Itch-independent degradative mechanisms of c-FLIP. 37, 38 In this study, we observed that the downregulation of FLIP L by hyperthermia in CX-1 cells is JNK-independent, Itchindependent, ATM-independent and ROS-independent. Thus, these discrepancies need to be further studied for clarification.
c-FLIP has been shown to be ubiquitinated and degraded via the proteasome or a lysosomal pathway. 20, 21, 39 Data from Figure 5c illustrate that the proteasome inhibitor MG132 inhibited the hyperthermia-mediated downregulation of c-FLIP L , but there was no restoration of c-FLIP L for lysosomal proteases inhibitor NH 4 Cl, confirming the existence of proteasome-mediated, but not lysosome-mediated, degradation of the protein. Ubiquitination assays further proved that the ubiquitination of c-FLIP L increased upon hyperthermia.
Ubiquitination is a post-translational modification used by cells to alter protein stability and function. 40 Protein ubiquitination is accomplished by the coordinated action of a series of proteins referred to as E1, E2 and E3 enzymes. E1 activates ubiquitination, triggering its transfer onto the Ub carrier enzyme E2, which in turn is transferred onto a substrate protein by an E3 ligase and the moiety becomes covalently linked. The repeated addition of ubiquitination moieties results in the formation of a polyubiquitinated substrate protein, which is recognized by a large proteolytic complex, the 26S proteasome. The Itchs (of which over 1000 are encoded in the human genome) catalyze the rate-limiting step of the process and facilitate the transfer of the activated ubiquitin protein to lysine (K) in the target protein. 41, 42 As Itch is not likely the E3 ligase for hyperthermia, it is worth discovering the lysine residues involved in the c-FLIP L ubiquitination, which will help to determine the E3 ligase of c-FLIP L after hyperthermia and may contribute to the sensitization. Serine 193 was reported to regulate c-FLIP s but not c-FLIP L ubiquitination and stability. 43 Lysines 192 and 195 were reported as c-FLIP S ubiquitination sites but not c-FLIP L by hemin treatment. 44 Thus, it is worthwhile to investigate the ubiquitination site of c-FLIP L by hyperthermia. In this study, the fragment analysis showed that the 1-200-aa region of c-FLIP L conferred instability after hyperthermia; however, unexpectedly, the fragment 1-240 aa was stable when exposed to hyperthermia (Figure 7a ). It is possible that the C-terminal of 1-240 aa covered the ubiquitination site of 1-200 aa and consequently disrupted the reliability of the hyperthermia.
The fragment ubquitination assay and the online software UbPred narrowed down the possible ubquitination site, and we found that K195 was responsible for ubiquitination, and thus degradation of c-FLIP L by hyperthermia. K195R transient transfectants partially protected from the hyperthermiainduced sensitization to Mapa-mediated apoptosis, indicating that other factors or pathways were still involved, which was in accord with our previous publication.
Taken together, we document here that hyperthermia may trigger a fast and robust reduction in c-FLIP L stability that the sensitization of Mapa induced by hyperthermia was a consequence of increased proteasomal degradation of FLIP L , and that the residue K195 was responsible for c-FLIP L ubiquitination. Such a general regulatory mechanism has broad ramifications for hyperthermia-mediated regulation of apoptosis. As this combination has an excellent translational potential, it should be considered for colorectal hepatic metastases treatment in clinics. Cell cycle analysis. Cells were harvested and fixed with 70% ethanol overnight. Cells were stained with PI/RNase staining buffer (BD Pharmingen) for 15 min at room temperature, subjected to flow cytometry (AccuriC6 Flow Cytometer, Accuri Cytometers) and analyzed by Flowjo7.6.1 software (Tree Star Inc., Ashland, VA, USA).
Knockdown of c-FLIP with siRNA oligomers. To generate c-FLIP-knockdown CX-1 cells, cells were transfected with 10 nM of siRNA FLIP (a pool of four target-specific 19-25 nt) and control siRNA from Santa Cruz Biotechnology, using Lipofectamine 2000 (Invitrogen). Expression levels were determined by immunoblot analysis.
Knockdown of itch with shRNA lentiviral infection. Itch shRNA lentivirus vectors were obtained from Santa Cruz Biotechnology along with the appropriate control vector. The infection procedure was performed according to the instructions provided by the company. After infection, stable clones were selected by treatment with puromycin. Itch knockdown levels were assessed by immunoblot analysis.
Quantitative reverse transcription-PCR analysis. Total RNA was extracted and purified from cultured cells using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions. The RNA was quantified by determining absorbance at 260 nm. Two micrograms of total RNA from each sample was reverse transcribed into cDNA using the High-Capacity cDNA Reverse Transcription Kit (Life Technologies Inc., Frederick, MD, USA) in a volume of 20 ml. qPCR was carried out using Applied Biosystems' (Carlsbad, CA, USA) inventoried TaqMan assays (20X Primer Probe mix), corresponding to CASP8-and FADD-like apoptosis regulator (CFLAR; assay ID Hs00153439_ m1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; assay ID Hs02758991_g1). All reactions were carried out with 2X TaqMan Universal PCR Master Mix (Applied Biosystems) on an Applied Biosystems StepOne Plus Real-Time PCR System, according to the standard protocols. The amount of each target gene relative to the housekeeping gene GAPDH was determined using the comparative threshold cycle (Ct) method (Applied Biosystems User Bulletin 2, http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf).
Immunoprecipitation. Briefly, cells were lysed in CHAPS lysis buffer with protease inhibitor cocktail (Calbiochem). Cell lysates were clarified by centrifugation at 13 000 r.p.m. for 15 min, and protein concentration was determined by BCA Protein Assay Reagent (Pierce Biotechnology, Rockford, IL, USA). For immunoprecipitation, 0.5-1 mg of lysate was incubated with 1.5 mg of rabbit antiBax or anti-Flag antibody or rabbit IgG (Santa Cruz Biotechnology) at 4 1C overnight, followed by the addition of protein A-agarose beads (Santa Cruz Biotechnology) and rotation at room temperature for 2 h. The beads were washed and resuspended in SDS sample buffer; this was followed by an immunoblot analysis.
Immunoblot analysis. Cells were lysed with Laemmli lysis buffer (2.4 M glycerol, 0.14 M Tris, pH 6.8, 0.21 M SDS, 0.3 mM bromophenol blue) and boiled for 10 min. Protein content was measured with BCA Protein Assay Reagent. The samples were diluted with 1 Â lysis buffer containing 1.28 M b-mercaptoethanol, and equal amounts of protein were loaded on 8-12% SDS-polyacrylamide gels. Proteins were separated by SDS-PAGE and electrophoretically transferred to nitrocellulose membrane. The nitrocellulose membrane was blocked with 5% nonfat dry milk in PBS-Tween-20 (0.1%, v/v) for 1 h. The membrane was incubated with primary antibody (diluted according to the manufacturer's instructions) at room temperature for 2 h. Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG was used as the secondary antibody. Immunoreactive protein was visualized by the chemiluminescence protocol (ECL, Amersham, Arlington Heights, IL, USA). To ensure equal protein loading, each membrane was stripped and reprobed with anti-actin antibody to normalize for differences in protein loading. Statistical analysis. Statistical analysis was carried out using Graphpad InStat 3 software (GraphPad Software, San Diego, CA, USA). Statistical significance is marked with asterisks (*Po0.05 and **Po0.01).
